Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (150) Arrow Down
Filter Results: (150) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (150)
    • News  (29)
    • Research  (100)
    • Events  (1)
  • Faculty Publications  (19)

Show Results For

  • All HBS Web  (150)
    • News  (29)
    • Research  (100)
    • Events  (1)
  • Faculty Publications  (19)
← Page 2 of 150 Results →
  • 2021
  • Working Paper

Regulatory Approval and Expanded Market Size

By: Benjamin Berger, Amitabh Chandra and Craig Garthwaite
Regulatory review of new medicines is often viewed as a hindrance to innovation by increasing the hurdle to bring products to market. However, a more complete accounting of regulation must also account for its potential market expanding effects through quality... View Details
Keywords: New Medicines; Regulatory Approval; Health Care and Treatment; Research and Development; Governing Rules, Regulations, and Reforms; Markets; Expansion; Pharmaceutical Industry
Citation
Find at Harvard
Read Now
Related
Berger, Benjamin, Amitabh Chandra, and Craig Garthwaite. "Regulatory Approval and Expanded Market Size." NBER Working Paper Series, No. 28889, June 2021.
  • 18 Dec 2018
  • First Look

New Research and Ideas, December 18, 2018

2018 Innovation Policy and the Economy The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century By: Bagley, Nicholas, Benjamin Berger, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern Abstract—On the 35th... View Details
Keywords: Dina Gerdeman
  • 26 Apr 2019
  • HBS Seminar

Maryaline Catillon, Harvard University

  • 22 Feb 2016
  • Research & Ideas

The ‘Mother of Fair Trade’ was an Unabashed Price Protectionist

Sawyer adds, “Gleason and others argued that their version of fair trade—albeit domestic oriented—offered higher wages, better services, and quality guarantees.” Prior to Gleason entering the scene, fair trade efforts had fallen flat.... View Details
Keywords: by Dina Gerdeman; Retail; Health; Legal Services
  • 07 Dec 2010
  • First Look

First Look: Dec. 7

perceived credit quality of the financial guarantors fell, and yields on insured bonds exceeded yields on equivalent uninsured issues. It does not appear that either property and casualty insurers or open-end municipal mutual funds were... View Details
Keywords: Sean Silverthorne
  • 09 Oct 2020
  • Blog Post

4 Things To Know About the MS/MBA Biotech

paying a stream of medical bills. My aversion to health care growing up, juxtaposed by the cost-free, quality care I received later in life as a US citizen, is why I want to work towards improving the health care system. I studied Biology... View Details
  • 12 Jul 2016
  • First Look

July 12, 2016

model is defaultable bank liabilities that provide liquidity services to households. The quality of the liquidity services provided by bank liabilities depends on their safety in case of default. Commercial bank debt is fully insured and... View Details
Keywords: Sean Silverthorne
  • November 2022
  • Case

The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales

By: Regina E. Herzlinger and Tiffany Farrell
Can an online, direct-to-consumer pharmacy both improve the quality and speed of care for patients who need branded drugs and stabilize profits for pharmaceutical manufacturers? UpScript, after years spent achieving legal and regulatory compliance and simultaneous... View Details
Keywords: DTC; Internet and the Web; Marketing Channels; Customer Value and Value Chain; Governing Rules, Regulations, and Reforms; Competitive Strategy; Service Delivery; Growth and Development Strategy; Pharmaceutical Industry; Health Industry; Retail Industry
Citation
Educators
Purchase
Related
Herzlinger, Regina E., and Tiffany Farrell. "The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales." Harvard Business School Case 323-031, November 2022.
  • August 2004 (Revised July 2006)
  • Case

PROPECIA TM: Helping Make Hair Loss History

By: Marta Wosinska and Youngme E. Moon
In late 1997, Tom Casola, brand manager for Propecia, debates the best approach to market this breakthrough one-a-day pill for hair loss. This launch would be atypical for a prescription drug because of the key position of the consumer. As a result, the team's... View Details
Keywords: Advertising; Communication Strategy; Customers; Marketing Communications; Marketing Strategy; Product Launch; Product; Performance Effectiveness; Problems and Challenges; Quality; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Wosinska, Marta, and Youngme E. Moon. "PROPECIA TM: Helping Make Hair Loss History." Harvard Business School Case 505-035, August 2004. (Revised July 2006.)
  • 14 Nov 2017
  • First Look

New Research and Ideas: November 14, 2017

applications, such as Snapchat filters, but AR is being applied in far more consequential ways in business. Pioneering organizations are already implementing it in product development, manufacturing, logistics, marketing, service, and training—and are seeing major... View Details
Keywords: Carmen Nobel
  • Web

Faculty & Advisors | MBA

way clinical trials bottlenecked the development of new treatments for patients, compelling him to start TrialSpark. TrialSpark is a tech-driven drug development company that can run higher quality clinical... View Details
  • 23 Sep 2008
  • First Look

First Look: September 23, 2008

teamwork in decision-making, the challenges of group decision-making, and the strategies for engaging team learning skills and attitudes to improve both the quality of and commitment to group decisions. Purchase the exercise:... View Details
Keywords: Martha Lagace
  • 10 Oct 2007
  • First Look

First Look: First Look: October 10

broad-based therapies. Instead, the focus should be on enrolling subpopulations, based on diagnostic testing, in trials of targeted drug treatments and on monitoring and assessing effectiveness after drugs... View Details
Keywords: Martha Lagace
  • Web

Degrees, Certifications & Alumni Status | About

credential programs on vital business topics, including negotiation, accounting, finance, and leadership, combining the flexibility of online learning with the rigor and quality of a Harvard Business School education to equip you with new... View Details
  • 20 Nov 2007
  • First Look

First Look: November 20, 2007

ownership patterns across different towns, allowing credible identification of the effects of bank ownership on financial development, lending rates, and the quality of intermediation, as well as employment and investment. Credit markets... View Details
Keywords: Martha Lagace
  • Web

General Management - Faculty & Research

governance trends. About the Unit The General Management Unit is concerned with the leadership and management of the enterprise as a whole. This concern encompasses: the personal values and qualities of effective general managers and... View Details
  • 01 Dec 2023
  • News

Wide Horizon

IP rights for suramin, a century-old drug historically used to treat African sleeping sickness, a parasitic disease, and later tested as a treatment for metastatic cancer. N of One had supported a trial by researchers at the University of... View Details
Keywords: Dan Morrell; Photos by Sarah Wilson
  • 02 Mar 2007
  • What Do You Think?

What Is the Government’s Role in US Health Care?

from government. Suggestions of causes of the current challenge of rapidly rising costs in relation to quality of outcomes, at least by the imperfect measure of life expectancy, included waste in the system (Julie Maire, Edward Hare, and... View Details
Keywords: by Jim Heskett; Health
  • 21 Feb 2018
  • Research & Ideas

When a Competitor Abandons the Market, Should You Advance or Retreat?

SolStock In late 2016 drug maker Eli Lilly announced it would stop research on the Alzheimer's drug solanezumab after results proved disappointing over three trials. For competitors such as Biogen, Merck,... View Details
Keywords: by Rachel Layne; Pharmaceutical; Health
  • 25 Jul 2023
  • Research & Ideas

Could a Business Model Help Big Pharma Save Lives and Profit?

With Hepatitis C running rampant in Egypt in 2012, Clifford Samuel, then of California-based Gilead Sciences, convened a series of urgent meetings with Egyptian government officials, doctors, and patients. His goal? To make Gilead’s lifesaving Hepatitis C View Details
Keywords: by Esther Schrader; Pharmaceutical; Health
  • ←
  • 2
  • 3
  • …
  • 7
  • 8
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.